More evidence that mixing COVID-19 vaccines may help elicit a robust immune response

By | June 29, 2021
Eight volunteers who received a complete dose or a single dose of an mRNA vaccine or the ChAdOx1 vaccine after a dose of a trial gorilla adenovirus vaccine showed a significantly high level of antibodies and T cell response against SARS-CoV-2.